Iroko Pharmaceuticals Acquires iCeutica Inc. to Bolster Capabilities in Novel Low-Dose NSAIDs

PHILADELPHIA--(BUSINESS WIRE)--Iroko Pharmaceuticals, LLC today announces that it has acquired iCeutica, Inc. to further strengthen Iroko’s position as the leading developer of novel, low-dose non-steroidal anti-inflammatory drugs (NSAIDs).